VURLIPAV
"VURLIPAV" is a word mark owned by Novartis AG, filed at IP Australia on August 17, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).
- Status
- Awaiting publication
- Since September 23, 2026
- Filed
- August 17, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 2687293
- Registration no.
- Not yet
- Office
- IP Australia
- IP Australia
- Mark type
- Word mark
- 1 class
Who owns VURLIPAV
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Novartis AG
NOVN · Basel, Switzerland
Representative
Davies Collison Cave Pty Ltd
Davies Collison Cave Pty Ltd
What the mark covers
The products and services VURLIPAV is filed for, grouped by Nice class.
pharmaceutical preparations
What has happened so far
Steps recorded by IP Australia, newest first.
- Early Acceptance Notice correspondence sent
- Awaiting examination
- Application Received
About VURLIPAV
Who owns the trademark "VURLIPAV"?
IP Australia trademark "VURLIPAV" (application 2687293) is owned by Novartis AG.
What is the status of "VURLIPAV"?
Its status at IP Australia is: awaiting publication.
Get this data via the API
Everything on this page comes from the Signa API. Pull VURLIPAV and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a01194-8e4d-7577-aa29-10eef8070704
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a01194-8e4d-7577-aa29-10eef8070704",
"object": "trademark",
"mark_text": "VURLIPAV",
"status": {
"primary": "pending",
"stage": "pending_publication"
},
"office_code": "AU",
"application_number": "2687293",
"filing_date": "2026-08-17",
"nice_classes": [
5
],
"owners": [
{
"name": "Novartis AG",
"entity_id": "ent_019ee98e-3962-72d9-8871-bdf198255e1a"
}
]
}